| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $100K | — | — |
| R&D Expense | $3.5M | — | +172.0% |
| SG&A Expense | $2.5M | — | -10.7% |
| Operating Income | -$6.0M | — | -44.9% |
| Income Tax | $0 | — | — |
| Net Income | -$5.7M | — | -43.4% |
| EPS (Basic) | -$0.11 | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.1M | +227.6% | +154.7% |
| Accounts Receivable | $65K | — | — |
| Current Assets | $50.8M | +422.3% | +333.8% |
| Total Assets | $64.2M | +176.7% | +161.7% |
| Current Liabilities | $6.0M | -0.9% | +74.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.7M | — | -52.5% |
| Capital Expenditures | $32K | — | — |
| Investing Cash Flow | -$21.5M | — | -3114.4% |
| Financing Cash Flow | $46.7M | — | — |
| Free Cash Flow | -$5.7M | — | -53.4% |
| EPS (Diluted) | -$0.11 | — | +76.1% |
| $8.1M |
| -2.3% |
| +20.0% |
| Stockholders' Equity | $56.0M | +276.6% | +215.6% |